Expression of type VI collagen in the developing mouse heart

Scott E Klewer, Sonja L. Krob, Sandra J. Kolker, Gregory T. Kitten

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

During development, the embryonic atrioventricular (AV) endocardial cushions undergo a morphogenic process to form mature valve leaflets and the membranous septa in the heart. Several extracellular matrix (ECM) proteins are expressed in the developing AV endocardial cushions, but it remains to be established if any specific ECM proteins are necessary for normal cushion morphogenesis. Abnormal development of the cardiac AV valves is a frequent cause of congenital heart defects, particularly in infants with trisomy 21 (Down syndrome). The genes encoding the α1 and α2 chains of type VI collagen are located on human chromosome 21 within the region thought to be critical for congenital heart defects in trisomy 21 infants. This suggests that the type VI collagen α1(VI) and α2(VI) chains may be important in normal AV valve morphogenesis. As a first step in understanding the role of type VI collagen in valve development, the authors examined the normal spatial and temporal expression patterns of mRNA and protein for type VI collagen in the embryonic mouse heart. Ribonuclease protection assay analysis demonstrates cardiac expression of the type VI collagen for α1(VI), α2(VI), and α3(VI) transcripts beginning at embryonic days 11-11.5 of mouse development. In situ hybridization studies demonstrate a coordinated pattern of cardiac expression within the AV valves for each type VI collagen chain from embryonic day 11.5 through the neonatal period. Immunohistochemical studies confirm a concentrated type VI collagen localization pattern in the endocardial cushions from the earliest stages of valve development through the neonatal period. These data indicate that type VI collagen is expressed in the developing AV canal in a pattern consistent with cushion tissue mesenchymal cell migration and proliferation, and suggest that type VI collagen plays a role in the morphogenesis of the developing cardiac AV endocardial cushions into the valve leaflets and membranous septa of the heart.

Original languageEnglish (US)
Pages (from-to)248-255
Number of pages8
JournalDevelopmental Dynamics
Volume211
Issue number3
DOIs
StatePublished - Mar 1998

Fingerprint

Collagen Type VI
Endocardial Cushions
Heart Septum
Down Syndrome
Morphogenesis
Congenital Heart Defects
Extracellular Matrix Proteins
Collagen Type I
Chromosomes, Human, Pair 21
Heart Valves
Human Chromosomes
Ribonucleases
Cell Movement
In Situ Hybridization
Cell Proliferation
Messenger RNA

Keywords

  • Congenital heart defects
  • Endocardial cushion
  • Heart development
  • Trisomy 21
  • Type VI collagen

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Expression of type VI collagen in the developing mouse heart. / Klewer, Scott E; Krob, Sonja L.; Kolker, Sandra J.; Kitten, Gregory T.

In: Developmental Dynamics, Vol. 211, No. 3, 03.1998, p. 248-255.

Research output: Contribution to journalArticle

Klewer, Scott E ; Krob, Sonja L. ; Kolker, Sandra J. ; Kitten, Gregory T. / Expression of type VI collagen in the developing mouse heart. In: Developmental Dynamics. 1998 ; Vol. 211, No. 3. pp. 248-255.
@article{a554ba7f22bf4f2dbdc810bbe3d85332,
title = "Expression of type VI collagen in the developing mouse heart",
abstract = "During development, the embryonic atrioventricular (AV) endocardial cushions undergo a morphogenic process to form mature valve leaflets and the membranous septa in the heart. Several extracellular matrix (ECM) proteins are expressed in the developing AV endocardial cushions, but it remains to be established if any specific ECM proteins are necessary for normal cushion morphogenesis. Abnormal development of the cardiac AV valves is a frequent cause of congenital heart defects, particularly in infants with trisomy 21 (Down syndrome). The genes encoding the α1 and α2 chains of type VI collagen are located on human chromosome 21 within the region thought to be critical for congenital heart defects in trisomy 21 infants. This suggests that the type VI collagen α1(VI) and α2(VI) chains may be important in normal AV valve morphogenesis. As a first step in understanding the role of type VI collagen in valve development, the authors examined the normal spatial and temporal expression patterns of mRNA and protein for type VI collagen in the embryonic mouse heart. Ribonuclease protection assay analysis demonstrates cardiac expression of the type VI collagen for α1(VI), α2(VI), and α3(VI) transcripts beginning at embryonic days 11-11.5 of mouse development. In situ hybridization studies demonstrate a coordinated pattern of cardiac expression within the AV valves for each type VI collagen chain from embryonic day 11.5 through the neonatal period. Immunohistochemical studies confirm a concentrated type VI collagen localization pattern in the endocardial cushions from the earliest stages of valve development through the neonatal period. These data indicate that type VI collagen is expressed in the developing AV canal in a pattern consistent with cushion tissue mesenchymal cell migration and proliferation, and suggest that type VI collagen plays a role in the morphogenesis of the developing cardiac AV endocardial cushions into the valve leaflets and membranous septa of the heart.",
keywords = "Congenital heart defects, Endocardial cushion, Heart development, Trisomy 21, Type VI collagen",
author = "Klewer, {Scott E} and Krob, {Sonja L.} and Kolker, {Sandra J.} and Kitten, {Gregory T.}",
year = "1998",
month = "3",
doi = "10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H",
language = "English (US)",
volume = "211",
pages = "248--255",
journal = "Developmental Dynamics",
issn = "1058-8388",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of type VI collagen in the developing mouse heart

AU - Klewer, Scott E

AU - Krob, Sonja L.

AU - Kolker, Sandra J.

AU - Kitten, Gregory T.

PY - 1998/3

Y1 - 1998/3

N2 - During development, the embryonic atrioventricular (AV) endocardial cushions undergo a morphogenic process to form mature valve leaflets and the membranous septa in the heart. Several extracellular matrix (ECM) proteins are expressed in the developing AV endocardial cushions, but it remains to be established if any specific ECM proteins are necessary for normal cushion morphogenesis. Abnormal development of the cardiac AV valves is a frequent cause of congenital heart defects, particularly in infants with trisomy 21 (Down syndrome). The genes encoding the α1 and α2 chains of type VI collagen are located on human chromosome 21 within the region thought to be critical for congenital heart defects in trisomy 21 infants. This suggests that the type VI collagen α1(VI) and α2(VI) chains may be important in normal AV valve morphogenesis. As a first step in understanding the role of type VI collagen in valve development, the authors examined the normal spatial and temporal expression patterns of mRNA and protein for type VI collagen in the embryonic mouse heart. Ribonuclease protection assay analysis demonstrates cardiac expression of the type VI collagen for α1(VI), α2(VI), and α3(VI) transcripts beginning at embryonic days 11-11.5 of mouse development. In situ hybridization studies demonstrate a coordinated pattern of cardiac expression within the AV valves for each type VI collagen chain from embryonic day 11.5 through the neonatal period. Immunohistochemical studies confirm a concentrated type VI collagen localization pattern in the endocardial cushions from the earliest stages of valve development through the neonatal period. These data indicate that type VI collagen is expressed in the developing AV canal in a pattern consistent with cushion tissue mesenchymal cell migration and proliferation, and suggest that type VI collagen plays a role in the morphogenesis of the developing cardiac AV endocardial cushions into the valve leaflets and membranous septa of the heart.

AB - During development, the embryonic atrioventricular (AV) endocardial cushions undergo a morphogenic process to form mature valve leaflets and the membranous septa in the heart. Several extracellular matrix (ECM) proteins are expressed in the developing AV endocardial cushions, but it remains to be established if any specific ECM proteins are necessary for normal cushion morphogenesis. Abnormal development of the cardiac AV valves is a frequent cause of congenital heart defects, particularly in infants with trisomy 21 (Down syndrome). The genes encoding the α1 and α2 chains of type VI collagen are located on human chromosome 21 within the region thought to be critical for congenital heart defects in trisomy 21 infants. This suggests that the type VI collagen α1(VI) and α2(VI) chains may be important in normal AV valve morphogenesis. As a first step in understanding the role of type VI collagen in valve development, the authors examined the normal spatial and temporal expression patterns of mRNA and protein for type VI collagen in the embryonic mouse heart. Ribonuclease protection assay analysis demonstrates cardiac expression of the type VI collagen for α1(VI), α2(VI), and α3(VI) transcripts beginning at embryonic days 11-11.5 of mouse development. In situ hybridization studies demonstrate a coordinated pattern of cardiac expression within the AV valves for each type VI collagen chain from embryonic day 11.5 through the neonatal period. Immunohistochemical studies confirm a concentrated type VI collagen localization pattern in the endocardial cushions from the earliest stages of valve development through the neonatal period. These data indicate that type VI collagen is expressed in the developing AV canal in a pattern consistent with cushion tissue mesenchymal cell migration and proliferation, and suggest that type VI collagen plays a role in the morphogenesis of the developing cardiac AV endocardial cushions into the valve leaflets and membranous septa of the heart.

KW - Congenital heart defects

KW - Endocardial cushion

KW - Heart development

KW - Trisomy 21

KW - Type VI collagen

UR - http://www.scopus.com/inward/record.url?scp=0031942167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031942167&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H

DO - 10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H

M3 - Article

C2 - 9520112

AN - SCOPUS:0031942167

VL - 211

SP - 248

EP - 255

JO - Developmental Dynamics

JF - Developmental Dynamics

SN - 1058-8388

IS - 3

ER -